The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 369 results:
Author Title Type [ Year(Desc)]
Filters: Author is Polyzos, Stergios A  [Clear All Filters]
2019
Venetsanaki, V., & Polyzos S. A. (2019).  Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives.. Curr Vasc Pharmacol. 17(6), 546-555.
Kountouras, J., Doulberis M., Polyzos S. A., & Katsinelos P. (2019).  Metabolic syndrome components including high abdominal obesity and sarcopenia in patients with inflammatory bowel disease.. Ann Gastroenterol. 32(2), 214.
Katsinelos, T., Doulberis M., Polyzos S. A., Papaefthymiou A., Katsinelos P., & Kountouras J. (2019).  Molecular links between Alzheimer's disease and Gastrointestinal microbiota with its-related metabolic syndrome: emphasis on Helicobacter pylori infection involvement.. Curr Mol Med.
Paschou, S. A., Polyzos S. A., Anagnostis P., Goulis D. G., Kanaka-Gantenbein C., Lambrinoudaki I., et al. (2019).  Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.. Endocrine.
Athyros, V. G., Polyzos S. A., Kountouras J., Katsiki N., Anagnostis P., Doumas M., et al. (2019).  Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block.. Curr Vasc Pharmacol.
Perakakis, N., Polyzos S. A., Yazdani A., Sala-Vila A., Kountouras J., Anastasilakis A. D., et al. (2019).  Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: a proof of concept study.. Metabolism. 154005.
Polyzos, S. A., Slavakis A., Koumerkeridis G., Katsinelos P., & Kountouras J. (2019).  Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort.. Horm Metab Res. 51(2), 134-140.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2019).  Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.. Metabolism. 92, 82-97.
Polyzos, S. A., & Mantzoros C. S. (2019).  Obesity: seize the day, fight the fat.. Metabolism. 92, 1-5.
Boutari, C., Polyzos S. A., & Mantzoros C. S. (2019).  Of mice and men: Why progress in the pharmacological management of obesity is slower than anticipated and what could be done about it?. Metabolism. 96, vi-xi.
Polyzos, S. A., Makras P., Tournis S., & Anastasilakis A. D. (2019).  Off-label uses of denosumab in metabolic bone diseases.. Bone. 129, 115048.
Kountouras, J., Doulberis M., Papaefthymiou A., Polyzos S. A., Vardaka E., Tzivras D., et al. (2019).  A perspective on risk factors for esophageal adenocarcinoma: emphasis on Helicobacter pylori infection.. Ann N Y Acad Sci. 1452(1), 12-17.
Pilitsi, E., Farr O. M., Polyzos S. A., Perakakis N., Nolen-Doerr E., Papathanasiou A-E., et al. (2019).  Pharmacotherapy of obesity: Available medications and drugs under investigation.. Metabolism. 92, 170-192.
Kountouras, J., Doulberis M., Papaefthymiou A., Polyzos S. A., Touloumtzi M., Vardaka E., et al. (2019).  The relationship between -related microbiota dysbiosis and gastrointestinal tract pathologies.. Scand J Gastroenterol. 1-2.
Polyzos, S. A., Kountouras J., Mavrouli M., Katsinelos P., Doulberis M., Gavana E., et al. (2019).  Selenoprotein P in Patients with Nonalcoholic Fatty Liver Disease.. Exp Clin Endocrinol Diabetes.
Panagiotou, G., Papakonstantinou E., Vagionas A., Polyzos S. A., & Mantzoros C. S. (2019).  Serum Levels of Activins, Follistatins, and Growth Factors in Neoplasms of the Breast: A Case-Control Study.. J Clin Endocrinol Metab. 104(2), 349-358.
Polyzos, S. A., Perakakis N., Boutari C., Kountouras J., Ghaly W., Anastasilakis A. D., et al. (2019).  Targeted analysis of three hormonal systems identifies molecules associated with the presence and severity of NAFLD.. J Clin Endocrinol Metab.
Doulberis, M., Papaefthymiou A., Kountouras J., Polyzos S. A., Srivastava S., Klokowska-Röetzler J., et al. (2019).  Vitamin D Deficiency and Unclear Abdominal Pain in Patients from Low- and Middle-Income Countries.. Int J Environ Res Public Health. 16(23), 
Anastasilakis, A. D., Papapoulos S. E., Polyzos S. A., Appelman-Dijkstra N. M., & Makras P. (2019).  Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial.. J Bone Miner Res.
2020
Doulberis, M., Srivastava S., Polyzos S. A., Kountouras J., Papaefthymiou A., Klukowska-Rötzler J., et al. (2020).  Active Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients.. J Clin Med. 9(4), 
Doulberis, M., Kotronis G., Gialamprinou D., Polyzos S. A., Papaefthymiou A., Katsinelos P., et al. (2020).  Alzheimer's disease and gastrointestinal microbiota; impact of infection involvement.. Int J Neurosci. 1-13.
Doulberis, M., Papaefthymiou A., Polyzos S. A., Bargiotas P., Liatsos C., Srivastava D. Shiva, et al. (2020).  Association between Active Infection and Glaucoma: A Systematic Review and Meta-Analysis.. Microorganisms. 8(6), 
Anastasilakis, A. D., Polyzos S. A., Yavropoulou M. P., & Makras P. (2020).  Combination and sequential treatment in women with postmenopausal osteoporosis.. Expert Opin Pharmacother. 21(4), 477-490.
Polyzos, S. A., Kang E. Seok, Tsochatzis E. A., Kechagias S., Ekstedt M., Xanthakos S., et al. (2020).  Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name.. Metabolism. 113, 154413.
Makri, E., Kita M., Goulas A., Papaioannidou P., Efstathiadou Z. A., Adamidou F., et al. (2020).  Comparative effectiveness of glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors on noninvasive indices of hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus.. Diabetes Metab Syndr. 14(6), 1913-1919.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.